-----Original Message-----
From: NIH news releases and news items [mailto:[log in to unmask]] On
Behalf Of NIH OLIB (NIH/OD)
Sent: Tuesday, August 10, 2010 2:24 PM
To: [log in to unmask]
Subject: NIH TO HOST INTERNATIONAL WEBCAST ON DUAL USE RESEARCH
U.S. Department of Health and Human Services
NATIONAL INSTITUTES OF HEALTH NIH News
NIH Office of the Director (OD) <http://www.nih.gov/icd/od/>
NIH Office of Biotechnology Activities (OBA)<http://oba.od.nih.gov/oba/>
For Immediate Release: Tuesday, August 10, 2010
CONTACTS:
NIH Office of Communications and Public Liaison, 301-496-5787
NIH Office of Biotechnology Activities, <e-mail:[log in to unmask]>
MEDIA AVAILABILITY
NIH TO HOST INTERNATIONAL WEBCAST ON DUAL USE RESEARCH
WHAT:
An international, interactive webcast, titled "Does Your Research Raise
Security Concerns? Strategies for Promoting Responsible Research in the Life
Sciences," will focus on dual use life science research issues.
Advances in the life sciences have the potential to transform our world.
From the discovery of novel antimicrobial compounds to the emerging
technologies of synthetic biology, scientific advances will lead to new
approaches to address human health and environmental and agricultural
challenges. Dual use research includes technologies that hold immense
promise but could be misused to pose a threat to public health and national
and international security.
This webcast is the second in a series of regional webcasts. This event
focuses on Europe with the goal of enhancing global dialogue on issues
related to dual use life sciences research. Questions will be submitted
electronically to the panel of experts from webcast participants, who are
anticipated to be individuals who are engaged in or have an interest in life
sciences research.
WHO:
The webcast is sponsored by the U.S. government and hosted by the National
Science Advisory Board for Biosecurity (NSABB), in partnership with the
European Molecular Biology Organization, the European Science Foundation,
the European Society of Clinical Microbiology and Infectious Diseases, and
the Pasteur Institute. NSABB is federal advisory committee that advises the
NIH director, the HHS secretary and other government departments, agencies
and offices that conduct, support or have an interest in the life sciences
on dual use research issues.
The Acting NIH Associate Director for Science Policy, members of NSABB and
European and American scientists and policy experts will present and discuss
concepts and examples of dual use research and strategies for management in
the context of research on antimicrobial resistance and synthetic biology.
Presenters include:
-- David R. Franz, D.V.M., Ph.D. , vice president and chief biological
scientist at the Midwest Research Institute in Frederick, Md .
-- Andrzej Gorski, M.D., vice president of the Polish Academy of Sciences
and chair of the InterAcademy Panel Working Group on Biosecurity in Warsaw,
Poland
-- Professor Dr. Oscar P. Kuipers, Molecular Genetics Group at the
Groningen Biomolecular Sciences and Biotechnology Institute at the
University of Groningen in the Netherlands
-- Stuart B. Levy, M.D., director of the Center for Adaptation Genetics and
Drug Resistance and professor of molecular biology, microbiology and
medicine at Tufts University School of Medicine in Boston
-- Amy P. Patterson, M.D., acting director of the Office of Science Policy
within the Office of the Director at the National Institutes of Health in
Bethesda, Md.
-- David A. Relman, M.D., professor of microbiology and immunology and
professor of medicine at the Stanford University School of Medicine in
Stanford, Calif.
Discussion facilitators will include staff from the World Health
Organization, the European Commission and others with policy and scientific
journal expertise.
WHEN:
Thursday, September 22, 8:00 AM-10:30 AM EDT
WHERE:
To participate in the webcast go to:
<http://oba.od.nih.gov/biosecurity/internationalwebcast_europe2010.html>.
The webcast will be archived at this link after the live, interactive event
is completed.
To learn more about the issue of dual use life science research, please view
the educational video available at <http://oba.od.nih.gov/biosecurity/>
The Office of the Director, the central office at NIH, is responsible for
setting policy for NIH, which includes 27 Institutes and Centers. This
involves planning, managing, and coordinating the programs and activities of
all NIH components. The Office of the Director also includes program offices
which are responsible for stimulating specific areas of research throughout
NIH. Additional information is available at <http://www.nih.gov/icd/od/>.
The National Institutes of Health (NIH) -- The Nation's Medical Research
Agency -- includes 27 Institutes and Centers and is a component of the U.S.
Department of Health and Human Services. It is the primary federal agency
for conducting and supporting basic, clinical and translational medical
research, and it investigates the causes, treatments, and cures for both
common and rare diseases. For more information about NIH and its programs,
visit <www.nih.gov>.
##
To subscribe (or unsubscribe) from this list, go to
<http://service.govdelivery.com/service/subscribe.html?code=USNIH_1>.
__________ Information from ESET NOD32 Antivirus, version of virus signature
database 5355 (20100810) __________
The message was checked by ESET NOD32 Antivirus.
http://www.eset.com
__________ Information from ESET NOD32 Antivirus, version of virus signature
database 5355 (20100810) __________
The message was checked by ESET NOD32 Antivirus.
http://www.eset.com
-----------------------
To change your mail settings or leave the C-PALSY list, go here:
http://listserv.icors.org/SCRIPTS/WA-ICORS.EXE?SUBED1=c-palsy
|
